December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

33.99 -0.23 (-0.67%)
Streaming Delayed Price Updated: 10:39 AM EDT, Apr 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Smith & Nephew SNATS, Inc. Common Stock

< Previous 1 2 3 4 Next >
News headline image
Current Analysis: Smith & Nephew ↗
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from... 
Via Talk Markets
News headline image
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Earnings Scheduled For August 3, 2023 ↗
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
News headline image
Will Investors Notice Exciting Sign On Smith & Nephew's Chart? ↗
 
Via Benzinga
News headline image
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
News headline image
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism ↗
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the... 
Via Benzinga
News headline image
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery ↗
 
Via Benzinga
News headline image
3 Millionaire-Maker Robotics Stocks to Buy in February 2024 ↗
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns. 
Via InvestorPlace
News headline image
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Santa Rally comes early for these stocks
The analysts are upgrading these stocks and are helping an early Santa Claus Rally drive their prices to new highs, with a double-digit upside ahead. 
Via MarketBeat
News headline image
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
News headline image
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength ↗
Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the  
Via Benzinga
News headline image
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares... 
Via Benzinga
News headline image
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck ↗
 
Via Benzinga
News headline image
Boeing, CyberArk Lead 5 Stocks Near Buy Points ↗
The market rally is going strong, but watch out for a potential pullback. 
Via Investor's Business Daily
News headline image
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
News headline image
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout ↗
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
News headline image
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
3 Healthcare Dividend Payers With Big Price Growth
Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers. 
Via MarketBeat
News headline image
Burberry Finance Chief Joins GSK As First Woman CFO ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's session saw 63 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 92 companies set new 52-week lows. 
Via Benzinga
News headline image
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.